//
Defining Staged Procedures for Percutaneous Coronary Intervention Trials A Guidance Document
Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or with Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights from the AUGUSTUS Trial
2017 ACC/AHA Blood Pressure Treatment Guideline Recommendations and Cardiovascular Risk
Routinely reported ejection fraction and mortality in clinical practice: where does the nadir of risk lie?
Dynamic atrioventricular delay programming improves ventricular electrical synchronization as evaluated by 3D vectorcardiography
Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial
Safety and feasibility of robotic percutaneous coronary intervention: PRECISE (Percutaneous Robotically-Enhanced Coronary Intervention) Study
Sudden Cardiac Arrest Survivorship: A Scientific Statement From the American Heart Association